Key stats
About Fidelity MSCI Health Care Index ETF
Home page
Inception date
Oct 21, 2013
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Distribution tax treatment
Qualified dividends
Income tax type
Capital Gains
Max ST capital gains rate
39.60%
Max LT capital gains rate
20.00%
Primary advisor
FMR Co., Inc.
Distributor
Fidelity Distributors Corp.
ISIN
US3160926008
FHLC casts a wide net across the entire health care market in the US, capturing over 300 large-, mid- and small-cap companies and spanning more than 10 subsectors. This diversification gives the vanilla fund less exposure to the big pharma companies that dominate the market, and more exposure to sectors like drug retailers and insurance. Prior to December 1, 2020, the fund tracked the MSCI USA IMI Health Care Index, an uncapped version of the present index. To meet diversification requirements, FHLC now uses a 25/50 capping methodology. Notably, instead of replicating the underlying index, the fund uses a representative sampling strategy. The index is rebalanced quarterly.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Stocks99.85%
Health Technology79.65%
Health Services13.51%
Distribution Services3.15%
Retail Trade1.61%
Technology Services1.23%
Commercial Services0.40%
Finance0.26%
Process Industries0.03%
Electronic Technology0.02%
Bonds, Cash & Other0.15%
Mutual fund0.11%
Miscellaneous0.02%
Cash0.02%
Stock breakdown by region
North America96.79%
Europe3.19%
Asia0.01%
Latin America0.01%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
FHLC invests in stocks. The fund's major sectors are Health Technology, with 79.65% stocks, and Health Services, with 13.51% of the basket. The assets are mostly located in the North America region.
FHLC top holdings are Eli Lilly and Company and Johnson & Johnson, occupying 10.54% and 7.19% of the portfolio correspondingly.
FHLC last dividends amounted to 0.26 USD. The quarter before, the issuer paid 0.26 USD in dividends, which shows a 0.39% decrease.
FHLC assets under management is 2.46 B USD. It's risen 0.22% over the last month.
FHLC fund flows account for −253.36 M USD (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
Yes, FHLC pays dividends to its holders with the dividend yield of 1.56%. The last dividend (Sep 23, 2025) amounted to 0.26 USD. The dividends are paid quarterly.
FHLC shares are issued by FMR LLC under the brand Fidelity. The ETF was launched on Oct 21, 2013, and its management style is Passive.
FHLC expense ratio is 0.08% meaning you'd have to pay 0.08% of your investment to help manage the fund.
FHLC follows the MSCI US IMI 25/50 Health Care. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
FHLC invests in stocks.
FHLC price has risen by 0.55% over the last month, and its yearly performance shows a −11.42% decrease. See more dynamics on FHLC price chart.
NAV returns, another gauge of an ETF dynamics, showed a 5.06% increase in three-month performance and has decreased by −8.87% in a year.
NAV returns, another gauge of an ETF dynamics, showed a 5.06% increase in three-month performance and has decreased by −8.87% in a year.
FHLC trades at a premium (0.03%) meaning the ETF is trading at a higher price than the calculated NAV.